Oluwaseun Egbejimi
Baylor College of Medicine
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Oluwaseun Egbejimi.
Journal of Biological Chemistry | 2006
David J. Durgan; Nowice A. Trexler; Oluwaseun Egbejimi; Tracy A. McElfresh; Hee Yun Suk; Lauren E. Petterson; Chad A. Shaw; Paul E. Hardin; Molly S. Bray; Margaret P. Chandler; Chi-Wing Chow; Martin E. Young
Cells/organs must respond both rapidly and appropriately to increased fatty acid availability; failure to do so is associated with the development of skeletal muscle and hepatic insulin resistance, pancreaticβ-cell dysfunction, and myocardial contractile dysfunction. Here we tested the hypothesis that the intrinsic circadian clock within the cardiomyocytes of the heart allows rapid and appropriate adaptation of this organ to fatty acids by investigating the following: 1) whether circadian rhythms in fatty acid responsiveness persist in isolated adult rat cardiomyocytes, and 2) whether manipulation of the circadian clock within the heart, either through light/dark (L/D) cycle or genetic disruptions, impairs responsiveness of the heart to fasting in vivo. We report that both the intramyocellular circadian clock and diurnal variations in fatty acid responsiveness observed in the intact rat heart in vivo persist in adult rat cardiomyocytes. Reversal of the 12-h/12-h L/D cycle was associated with a re-entrainment of the circadian clock within the rat heart, which required 5–8 days for completion. Fasting rats resulted in the induction of fatty acid-responsive genes, an effect that was dramatically attenuated 2 days after L/D cycle reversal. Similarly, a targeted disruption of the circadian clock within the heart, through overexpression of a dominant negative CLOCK mutant, severely attenuated induction of myocardial fatty acid-responsive genes during fasting. These studies expose a causal relationship between the circadian clock within the cardiomyocyte with responsiveness of the heart to fatty acids and myocardial triglyceride metabolism.
International Journal of Obesity | 2010
Molly S. Bray; Ju-Yun Tsai; Carolina Villegas-Montoya; Brandon B. Boland; Zackary Blasier; Oluwaseun Egbejimi; Michael Kueht; Martin E. Young
Background:Excess caloric intake is strongly associated with the development of increased adiposity, glucose intolerance, insulin resistance, dyslipidemia, and hyperleptinemia (that is the cardiometabolic syndrome). Research efforts have focused attention primarily on the quality (that is nutritional content) and/or quantity of ingested calories as potential causes for diet-induced pathology. Despite growing acceptance that biological rhythms profoundly influence energy homeostasis, little is known regarding how the timing of nutrient ingestion influences development of common metabolic diseases.Objective:To test the hypothesis that the time of day at which dietary fat is consumed significantly influences multiple cardiometabolic syndrome parameters.Results:We report that mice fed either low- or high-fat diets in a contiguous manner during the 12 h awake/active period adjust both food intake and energy expenditure appropriately, such that metabolic parameters are maintained within a normal physiologic range. In contrast, fluctuation in dietary composition during the active period (as occurs in human beings) markedly influences whole body metabolic homeostasis. Mice fed a high-fat meal at the beginning of the active period retain metabolic flexibility in response to dietary challenges later in the active period (as revealed by indirect calorimetry). Conversely, consumption of high-fat meal at the end of the active phase leads to increased weight gain, adiposity, glucose intolerance, hyperinsulinemia, hypertriglyceridemia, and hyperleptinemia (that is cardiometabolic syndrome) in mice. The latter perturbations in energy/metabolic homeostasis are independent of daily total or fat-derived calories.Conclusions:The time of day at which carbohydrate versus fat is consumed markedly influences multiple cardiometabolic syndrome parameters.
American Journal of Physiology-heart and Circulatory Physiology | 2005
David J. Durgan; Margaret A. Hotze; Tara M. Tomlin; Oluwaseun Egbejimi; Christophe Graveleau; E. Dale Abel; Chad A. Shaw; Molly S. Bray; Paul E. Hardin; Martin E. Young
American Journal of Physiology-heart and Circulatory Physiology | 2006
David J. Durgan; Justin Smith; Margaret A. Hotze; Oluwaseun Egbejimi; Karalyn D. Cuthbert; Vlad G. Zaha; Jason R. B. Dyck; E. Dale Abel; Martin E. Young
American Journal of Physiology-heart and Circulatory Physiology | 2007
David J. Durgan; Michael W. S. Moore; Ngan P. Ha; Oluwaseun Egbejimi; Anna Fields; Uchenna Mbawuike; Anu Egbejimi; Chad A. Shaw; Molly S. Bray; Vijayalakshmi Nannegari; Diane L. Hickson-Bick; William C. Heird; Jason R. B. Dyck; Margaret P. Chandler; Martin E. Young
Journal of Molecular and Cellular Cardiology | 2007
Theodore A. Kung; Oluwaseun Egbejimi; Jiajia Cui; Ngan P. Ha; David J. Durgan; M. Faadiel Essop; Molly S. Bray; Chad A. Shaw; Paul E. Hardin; William C. Stanley; Martin E. Young
Journal of Lipid Research | 2008
Joseph B. Lockridge; Mary L. Sailors; David J. Durgan; Oluwaseun Egbejimi; William J. Jeong; Molly S. Bray; William C. Stanley; Martin E. Young
Journal of Molecular and Cellular Cardiology | 2013
Ju Yun Tsai; Carolina Villegas-Montoya; Brandon B. Boland; Zachary Blasier; Oluwaseun Egbejimi; Raquel Gonzalez; Michael Kueht; Tracy A. McElfresh; Rachel A. Brewer; Margaret P. Chandler; Molly S. Bray; Martin E. Young
Circulation | 2006
David J. Durgan; Oluwaseun Egbejimi; Martin E. Young
Circulation | 2006
David J. Durgan; Melanie Fischer; Oluwaseun Egbejimi; Molly S. Bray; Chi-Wing Chow; Jason R. B. Dyck; Martin E. Young